MbrlCatalogueTitleDetail

Do you wish to reserve the book?
Efficacy of oral afoxolaner against Amblyomma maculatum infestations in dogs
Efficacy of oral afoxolaner against Amblyomma maculatum infestations in dogs
Hey, we have placed the reservation for you!
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Efficacy of oral afoxolaner against Amblyomma maculatum infestations in dogs
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Title added to your shelf!
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Efficacy of oral afoxolaner against Amblyomma maculatum infestations in dogs
Efficacy of oral afoxolaner against Amblyomma maculatum infestations in dogs

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
How would you like to get it?
We have requested the book for you! Sorry the robot delivery is not available at the moment
We have requested the book for you!
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Efficacy of oral afoxolaner against Amblyomma maculatum infestations in dogs
Efficacy of oral afoxolaner against Amblyomma maculatum infestations in dogs
Journal Article

Efficacy of oral afoxolaner against Amblyomma maculatum infestations in dogs

2025
Request Book From Autostore and Choose the Collection Method
Overview
Amblyomma maculatum , the Gulf Coast tick, is a species of significant veterinary and public health importance, especially because it is a vector of important diseases, such as American canine hepatozoonosis and tidewater spotted fever. Amblyomma maculatum infests a wide range of vertebrates including livestock, dogs, cats, and humans. Two experimental studies were conducted to evaluate the efficacy of afoxolaner formulated in an oral tablet (NexGard ® ) against induced infestations of A. maculatum in dogs. These Good Clinical Practice (GCP) studies used a randomized, negative controlled and masked design. In each study, 10 dogs were allocated to an untreated group and 10 dogs to a treated group, dosed once on Day 0 with a combination of tablets targeting the minimum therapeutic dose (2.5 mg/kg afoxolaner). Dogs were infested with 50 unfed adult A. maculatum on Days −2, 7, 14, 21, 28, and 35 (Study #1), or on Days −1, 14, and 28 (Study #2). Seventy-two (72) hours after treatment and subsequent infestations, ticks were removed and the numbers of live ticks in each group were used for efficacy calculations. At each time-point, all untreated dogs were adequately infested ( i.e. , with more than 12 live ticks), demonstrating a vigorous tick population and an adequate study model. The curative efficacy against established infestations, 72 hours after treatment, was 100% in Study #1 and 99.5% in Study #2. The preventive efficacy, 72 hours after the post-treatment infestations, ranged from 94.6% to 98.9% for five weeks in Study #1, and was ≥98.8% for four weeks in Study #2. Amblyomma maculatum , la tique du Golfe du Mexique, est une espèce d’importance vétérinaire et de santé publique considérable, notamment parce qu’elle est vectrice de maladies graves, telles que l’hépatozoonose canine américaine et la fièvre pourprée des marées. Amblyomma maculatum infeste un large éventail de vertébrés, notamment le bétail, les chiens, les chats et les humains. Deux études expérimentales ont été menées pour évaluer l’efficacité de l’afoxolaner sous forme de comprimé oral (NexGard ® ) contre les infestations induites d’ A. maculatum chez le chien. Ces études, conformes aux Bonnes Pratiques Cliniques (BPC), ont été randomisées, contrôlées par voie négative et en aveugle. Dans chaque étude, 10 chiens ont été répartis en un groupe non traité et 10 chiens en un groupe traité, recevant une dose unique le jour 0 d’une combinaison de comprimés ciblant la dose thérapeutique minimale (2,5 mg/kg d’afoxolaner). Les chiens ont été infestés par 50 A. maculatum adultes à jeun les jours −2, 7, 14, 21, 28 et 35 (étude n° 1), ou les jours −1, 14 et 28 (étude n° 2). Soixante-douze (72) heures après le traitement et les infestations ultérieures, les tiques ont été retirées et le nombre de tiques vivantes dans chaque groupe a été utilisé pour les calculs d’efficacité. À chaque point temporel, tous les chiens non traités étaient adéquatement infestés (c’est-à-dire avec plus de 12 tiques vivantes), démontrant une population de tiques vigoureuse et un modèle d’étude adéquat. L’efficacité curative contre les infestations établies, 72 heures après le traitement, était de 100% (étude n° 1) et de 99,5 % (étude n° 2). L’efficacité préventive, 72 heures après les infestations post-traitement, variait de 94,6 % à 98,9 % pendant cinq semaines dans l’étude n° 1, et était ≥ 98,8 %, pendant quatre semaines dans l’étude n° 2.